Relmada Therapeutics, Inc. (RLMD)
3.72
-0.18
(-4.62%)
USD |
NASDAQ |
Feb 13, 16:00
3.73
+0.01
(+0.27%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (Quarterly) : -0.304 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Invivyd, Inc. | -0.0615 |
| Arcellx, Inc. | -0.9858 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.09M |
| Total Expenses (Quarterly) | 10.09M |
| Enterprise Value | 258.91M |
| Earnings Yield | -48.31% |
| Normalized Earnings Yield | -48.26 |